Sean Lavin
Stock Analyst at BTIG
(3.08)
# 1,303
Out of 5,051 analysts
45
Total ratings
81.82%
Success rate
38.68%
Average return
Main Sectors:
Stocks Rated by Sean Lavin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TCMD Tactile Systems Technology | Downgrades: Neutral | n/a | $24.21 | - | 4 | Nov 5, 2024 | |
| HOLX Hologic | Downgrades: Neutral | n/a | $74.23 | - | 5 | Jul 18, 2022 | |
| PODD Insulet | Upgrades: Buy | $320 | $314.44 | +1.77% | 5 | Feb 3, 2022 | |
| MDT Medtronic | Downgrades: Neutral | n/a | $90.40 | - | 1 | Jan 10, 2022 | |
| ATRC AtriCure | Maintains: Buy | $42 → $48 | $32.32 | +48.51% | 3 | Feb 19, 2020 | |
| MASI Masimo | Downgrades: Neutral | n/a | $142.06 | - | 4 | Apr 16, 2019 | |
| HSDT Solana Company | Downgrades: Neutral | n/a | $5.07 | - | 4 | Apr 16, 2019 | |
| IRTC iRhythm Technologies | Upgrades: Buy | $80 | $180.49 | -55.68% | 3 | Apr 3, 2019 | |
| NEO NeoGenomics | Upgrades: Outperform | n/a | $10.43 | - | 4 | Apr 16, 2018 | |
| EXAS Exact Sciences | Upgrades: Buy | n/a | $69.63 | - | 3 | Apr 3, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $124.54 | - | 1 | Jan 22, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $98.90 | - | 1 | Nov 30, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $59.28 | - | 3 | May 3, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $82.84 | - | 4 | Feb 2, 2017 |
Tactile Systems Technology
Nov 5, 2024
Downgrades: Neutral
Price Target: n/a
Current: $24.21
Upside: -
Hologic
Jul 18, 2022
Downgrades: Neutral
Price Target: n/a
Current: $74.23
Upside: -
Insulet
Feb 3, 2022
Upgrades: Buy
Price Target: $320
Current: $314.44
Upside: +1.77%
Medtronic
Jan 10, 2022
Downgrades: Neutral
Price Target: n/a
Current: $90.40
Upside: -
AtriCure
Feb 19, 2020
Maintains: Buy
Price Target: $42 → $48
Current: $32.32
Upside: +48.51%
Masimo
Apr 16, 2019
Downgrades: Neutral
Price Target: n/a
Current: $142.06
Upside: -
Solana Company
Apr 16, 2019
Downgrades: Neutral
Price Target: n/a
Current: $5.07
Upside: -
iRhythm Technologies
Apr 3, 2019
Upgrades: Buy
Price Target: $80
Current: $180.49
Upside: -55.68%
NeoGenomics
Apr 16, 2018
Upgrades: Outperform
Price Target: n/a
Current: $10.43
Upside: -
Exact Sciences
Apr 3, 2018
Upgrades: Buy
Price Target: n/a
Current: $69.63
Upside: -
Jan 22, 2018
Downgrades: Neutral
Price Target: n/a
Current: $124.54
Upside: -
Nov 30, 2017
Upgrades: Buy
Price Target: n/a
Current: $98.90
Upside: -
May 3, 2017
Downgrades: Neutral
Price Target: n/a
Current: $59.28
Upside: -
Feb 2, 2017
Downgrades: Neutral
Price Target: n/a
Current: $82.84
Upside: -